In 2001, our group described a reduced frequency of CD4+ and CD8+ T lymphocytes and a poor ability for T‐lymphocyte proliferation in response to mitogens and dengue antigens in acute DENV‐infected patients, but re‐established in convalescence phase 48. This evidence concerns the gene CD4 and dengue disease.